Schedule 13G ownership disclosure
GLOBAL BLOOD THERAPEUTICS INC
Security class unavailable · CUSIP: 37890U108
Event date: 2020-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 5,966,862
- Percent of class
- 9.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-21-000082
- Form type
- SC 13G
- Filer
- Global Blood Therapeutics, Inc.
- CIK
- CIK 1629137
- Filed
- Feb 12, 2021
- Reporting period
- Dec 31, 2020
- Description
- Schedule 13G beneficial ownership